Vycor Medical (VYCO) EBITDA (2010 - 2026)
Vycor Medical (VYCO) reported EBITDA of $20108.0 for Q1 2026, up 152.14% year-over-year from $7974.8 in Q1 2025, and up 132.08% on a QoQ basis from -$62686.0 in Q4 2025.
Vycor Medical (VYCO) has 17 years of EBITDA data on file, last reported at $20108.0 in Q1 2026.
- Quarterly EBITDA rose 152.14% year-over-year to $20108.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$13755.0 (up 88.06% YoY) and the FY2025 annual result came in at -$72426.0, up 32.44% from the prior year.
- EBITDA improved to $20108.0 in Q1 2026 per VYCO's latest filing, from -$62686.0 in the prior quarter.
- Across five years, EBITDA topped out at $68408.0 in Q2 2023 and bottomed at -$116548.0 in Q4 2022.
- The 5-year median for EBITDA is -$38563.0 (2025), against an average of -$37301.4.
- The widest annual swing landed in 2022, when EBITDA tumbled 3205.38%; it then jumped 337.97% in 2025.
- Tracing VYCO's EBITDA over 5 years: stood at -$116548.0 in 2022, then grew by 20.16% to -$93055.0 in 2023, then surged by 92.76% to -$6737.0 in 2024, then slumped by 830.47% to -$62686.0 in 2025, then surged by 132.08% to $20108.0 in 2026.
- Per Business Quant, the three latest VYCO EBITDA figures stand at $20108.0 (Q1 2026), -$62686.0 (Q4 2025), and $4936.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.35 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 936.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.46 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.10 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 477.60 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 663.81 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 255.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 515.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 316.80 Mn |
| 10 | Vycor Medical | - | - | 375,153.00 | 20,108.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20,108.00 |
| Dec 31, 2025 | -62,686.00 |
| Sep 30, 2025 | 4,936.00 |
| Jun 30, 2025 | 23,887.00 |
| Mar 31, 2025 | -38,563.00 |
| Dec 31, 2024 | -6,737.00 |
| Sep 30, 2024 | -59,817.00 |
| Jun 30, 2024 | -10,038.00 |
| Mar 31, 2024 | -30,608.00 |
| Dec 31, 2023 | -93,055.00 |
| Sep 30, 2023 | -51,904.00 |
| Jun 30, 2023 | 68,408.00 |
| Mar 31, 2023 | 6,862.00 |
| Dec 31, 2022 | -116,548.00 |
| Sep 30, 2022 | -114,806.00 |
| Jun 30, 2022 | -99,011.00 |
| Mar 31, 2022 | -74,551.00 |
| Dec 31, 2021 | -187,063.00 |
| Sep 30, 2021 | 3,697.00 |
| Jun 30, 2021 | -9,379.00 |
| Mar 31, 2021 | -242,912.00 |
| Dec 31, 2020 | -200,366.00 |
| Sep 30, 2020 | -198,284.00 |
| Jun 30, 2020 | -248,887.00 |
| Mar 31, 2020 | -174,946.00 |
| Dec 31, 2019 | -220,990.00 |
| Sep 30, 2019 | -209,602.00 |
| Jun 30, 2019 | -130,545.00 |
| Mar 31, 2019 | -162,838.00 |
| Dec 31, 2018 | -464,813.00 |
| Sep 30, 2018 | -132,724.00 |
| Jun 30, 2018 | -414,917.00 |
| Mar 31, 2018 | -327,798.00 |
| Dec 31, 2017 | -374,544.00 |
| Sep 30, 2017 | -426,674.00 |
| Jun 30, 2017 | -363,676.00 |
| Mar 31, 2017 | -312,791.00 |
| Dec 31, 2016 | -489,895.00 |
| Sep 30, 2016 | -330,394.00 |
| Jun 30, 2016 | -302,442.00 |
| Mar 31, 2016 | -615,882.00 |
| Dec 31, 2015 | -432,141.00 |
| Sep 30, 2015 | -490,434.00 |
| Jun 30, 2015 | -401,191.00 |
| Mar 31, 2015 | -906,279.00 |
| Sep 30, 2014 | -1.28 Mn |
| Jun 30, 2014 | -1.27 Mn |
| Mar 31, 2014 | -787,488.00 |
| Dec 31, 2013 | -592,709.00 |
| Sep 30, 2013 | -506,909.00 |
| Jun 30, 2013 | -546,051.00 |
| Mar 31, 2013 | -536,670.00 |
| Dec 31, 2012 | -467,890.00 |
| Sep 30, 2012 | -699,701.00 |
| Jun 30, 2012 | -676,776.00 |
| Mar 31, 2012 | -702,571.00 |
| Dec 31, 2011 | -760,099.00 |
| Sep 30, 2011 | -908,867.00 |
| Jun 30, 2011 | -1.85 Mn |
| Mar 31, 2011 | -950,866.00 |
| Dec 31, 2010 | -852,742.00 |
| Sep 30, 2010 | -347,636.00 |
| Jun 30, 2010 | -408,388.00 |